Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Obesity Studies

Fatty Acid Transport Protein 1 Is Required for Nonshivering Thermogenesis in Brown Adipose Tissue

  1. Qiwei Wu1,
  2. Melissa Kazantzis1,
  3. Holger Doege1,
  4. Angelica M. Ortegon2,
  5. Bernice Tsang2,
  6. Alaric Falcon1 and
  7. Andreas Stahl12
  1. 1Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California
  2. 2Palo Alto Medical Foundation Research Institute, Palo Alto, California
  1. Address correspondence and reprint requests to Andreas Stahl, PhD, Palo Alto Medical Foundation, Research Institute, Ames Building, 795 El Camino Real, Palo Alto, CA 94301. E-mail: astahl{at}stanford.edu
Diabetes 2006 Dec; 55(12): 3229-3237. https://doi.org/10.2337/db06-0749
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    A: The effect of cold treatment on the expression of FATPs in brown fat. Mice were exposed to 4°C for 12 h before their BATs were taken. a, no cold-exposed BAT; b, cold-exposed BAT; c, muscle lysate control; d, liver lysate control; e, lung lysate control; f, heart lysate control. B: Cold-induced gene expression of FATP1 and UCP-1 expression in brown fat tissues. Expression level was analyzed by densitometry and normalized to the expression of β-tublin.

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    A: Localization of FATP1 in brown fat. Frozen brown fat sections were paraformaldehyde fixed and incubated with anti-FATP1 antibody, followed by Cy5-tagged goat anti-rabbit secondary antibody, and analyzed by immunofluorescence microscopy. B: Three-dimensional surface projects of FATP1 (red), integrin α6 (green), as well as their superimposition (right panels) of 15-μm sections of BAT from wild-type (WT) mice at 4°C. Nuclei were stained with DAPI (4′,6-diamidino-2-phenylinodole) (blue).

  • FIG. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Histology of brown fat shows lipid accumulation in adipocytes. A: Interscapular brown fat was removed from 8-week-old FATP1 KO and wild-type (WT) littermates. Paraffin-embedded sections were stained with hematoxylin and eosin. B: Three-dimensional reconstructions of frozen BAT section from FATP1 wild-type and KO mice stained with BODIPY fluorophore 493/503 for neutral lipids (yellow) and DAPI for nuclei (blue). One grid corresponds to 23 μmol/l. C: Uptake of a fluorescently labeled long-chain fatty acid by primary brown adipocytes from FATP1 wild-type and KO animals following cold or 0.5 mg/kg body wt of norepinephrine (NE) treatment. D: Western blot analysis of FATP1 and UCP-1. The expression of the UCP-1 increase after exposure to cold in both wild-type and FATP1-null BAT pads. Level of β-tublin (Tub) in BAT pads were used as a loading control.

  • FIG. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    FATP-null mice are unable to maintain core body temperature during fasting and cold exposure. A: Colonic temperature was recorded at 1, 3, 6, 12, and 24 h of fasting mice in cold treatment; right panel is the reading of fed mice in cold treatment. B: Levels of serum nonesterified fatty acids in both wild-type (WT) and FATP1-null mice in response to the cold exposure. C: Indirect calorimetry comparing the increases in O2 consumption and CO2 production rates during a 1-h phase, following injection of the β3-AR agonist CL316,243 in FATP1 KO mice (□) and wild-type littermates (▪). *P < 0.05 in paired Student’s t test.

  • FIG. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Effect of isoproterenol on long-chain fatty acid uptake. A: Expression of FATP1 and UCP-1 in cultured cells. Fibroblasts 3T3-L1 (black bar), HIB-1B preadipocytes (gray bar), HIB-1B adipocytes (green bar), and HIB-1B adipocytes + isoproterenol are indicated. Isotproterenol (10 μmol/l) was added into the medium 1 h before harvesting the cells for Western blot. Level of expression was analyzed by densitometry and normalized to the expression of β-tublin. B: Comparison of kinetic readings of long-chain fatty acid uptake by HIB adipocytes. □, untreated cells; ♦, 10 μmol/l isoproterenol treated cells. C: Effects of duration and dose of isopreterenol stimulus on initial uptake of long-chain fatty acid in HIB adipocytes. D: Fatty acid uptake 1 h after a 10 μmol/l isoproterenol stimulation and FATP1 expression. /, control; GP, Gs inhibitor (2 nmol/l pertussis toxin); MEK, MEK II inhibitor (10 nmol/l U0126); PKA, PKA inhibitor (10 nmol/l H89); TC, transcription inhibitor (1 μmol/l α-amanitin); TL, translation inhibitor (1 μmol/l NSC119889).

  • FIG. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Effects of FATP1 RNA interference (RNAi) on FATP1 expression and fatty acid uptake in HIB-1B cells. Upper panel: Expression of FATP1 was analyzed by Western blot analysis in HIB, HIB-SCR (scrambled RNAi), and HIB-1.5 (FATP1 RNAi) cell lines. These cells were incubated with solvent (basal), 1 nmol/l insulin, 50 nmol/l insulin, 100 nmol/l insulin (ins), 10 μmol/l isoproterenol (iso), and both (iso+ins) for 1 h. Lower panel: Stimulation of adrenergic agonist and insulin induce increased uptake fatty acid in HIB cells, and this effect was suppressed by RNA interference in the stable cell line of FATP1 RNAi. HIB cell lines were incubated in the presence of insulin, isoproterenol, or both at indicated concentration for 1 h and then assayed for fatty acid transport into the cells as described in research design and methods. Data are representative of three independent experiments.

PreviousNext
Back to top

In this Issue

December 2006, 55(12)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Fatty Acid Transport Protein 1 Is Required for Nonshivering Thermogenesis in Brown Adipose Tissue
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Fatty Acid Transport Protein 1 Is Required for Nonshivering Thermogenesis in Brown Adipose Tissue
Qiwei Wu, Melissa Kazantzis, Holger Doege, Angelica M. Ortegon, Bernice Tsang, Alaric Falcon, Andreas Stahl
Diabetes Dec 2006, 55 (12) 3229-3237; DOI: 10.2337/db06-0749

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Fatty Acid Transport Protein 1 Is Required for Nonshivering Thermogenesis in Brown Adipose Tissue
Qiwei Wu, Melissa Kazantzis, Holger Doege, Angelica M. Ortegon, Bernice Tsang, Alaric Falcon, Andreas Stahl
Diabetes Dec 2006, 55 (12) 3229-3237; DOI: 10.2337/db06-0749
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Deficiency of Stat1 in CD11c+ Cells Alters Adipose Tissue Inflammation and Improves Metabolic Dysfunctions in Mice Fed a High-Fat Diet
  • Placental Insulin/IGF-1 Signaling, PGC-1α, and Inflammatory Pathways Are Associated With Metabolic Outcomes at 4–6 Years of Age: The ECHO Healthy Start Cohort
  • Defective FXR-SHP Regulation in Obesity Aberrantly Increases miR-802 Expression, Promoting Insulin Resistance and Fatty Liver
Show more Obesity Studies

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.